PharmaShots | Incisive News in 3 Shots

Subscribe Now

Preclinical

Nektar Therapeutics Presents Preclinical Data of NKTR-255 in P-Ib/II Study at ASH 2020

Nektar Therapeutics Presents Preclinical Data of NKTR-255 in P-Ib/II Study at ASH 2020

December 8, 2020

Boehringer Ingelheim Acquires Northern Biologics' Preclinical Cancer Antibody Pipeline to Bolster its Immuno-oncology Portfolio

Boehringer Ingelheim Acquires Northern Biologics' Preclinical Cancer Antibody Pipeline to Bolster its Immuno-oncology Portfolio

May 15, 2020

Gilead Signs an Exclusive Worldwide License Agreement with Novartis for its Three Preclinical Antiviral Programs

Gilead Signs an Exclusive Worldwide License Agreement with Novartis for its Three Preclinical Antiviral Programs

July 19, 2019

Genentech Acquires Jecure Therapeutics for its Preclinical Stage NLRP3 inhibitors

Genentech Acquires Jecure Therapeutics for its Preclinical Stage NLRP3 inhibitors

November 29, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us